 |
 |
GEO help: Mouse over screen elements for information. |
|
| Status |
Public on Apr 12, 2024 |
| Title |
DUSP6 inhibition overcomes neuregulin/HER3-driven therapy tolerance in HER2+ breast cancer |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| Web link |
https://pubmed.ncbi.nlm.nih.gov/38886591/
|
| |
|
| Citation(s) |
38886591 |
| |
| Submission date |
May 02, 2023 |
| Last update date |
Jul 12, 2024 |
| Contact name |
Teemu Daniel Laajala |
| E-mail(s) |
[email protected]
|
| Organization name |
University of Turku
|
| Department |
Department of Mathematics and Statistics
|
| Street address |
Turun yliopisto
|
| City |
Turku |
| ZIP/Postal code |
20014 |
| Country |
Finland |
| |
|
| Platforms (2) |
| GPL21290 |
Illumina HiSeq 3000 (Homo sapiens) |
| GPL24676 |
Illumina NovaSeq 6000 (Homo sapiens) |
|
| Samples (18)
|
| GSM7287665 |
MDA-MB-453, Scrambled, Sample ID 1, rep1 |
| GSM7287666 |
MDA-MB-453, Scrambled, Sample ID 2, rep2 |
| GSM7287667 |
MDA-MB-453, Scrambled, Sample ID 4, rep3 |
| GSM7287668 |
MDA-MB-453, DUSP6 Knockdown, Sample ID 3, rep1 |
| GSM7287669 |
MDA-MB-453, DUSP6 Knockdown, Sample ID 5, rep2 |
| GSM7287670 |
MDA-MB-453, DUSP6 Knockdown, Sample ID 6, rep3 |
| GSM7287671 |
BT474, Control, Day 0, rep1 |
| GSM7287672 |
BT474, Control, Day 0, rep2 |
| GSM7287673 |
BT474, Control, Day 0, rep3 |
| GSM7287674 |
BT474, DTP, Day 9, rep1 |
| GSM7287675 |
BT474, DTP, Day 9, rep2 |
| GSM7287676 |
BT474, DTP, Day 9, rep3 |
| GSM7287677 |
BT474, DTEP, Month 6, rep1 |
| GSM7287678 |
BT474, DTEP, Month 6, rep2 |
| GSM7287679 |
BT474, DTEP, Month 6, rep3 |
| GSM7287680 |
BT474, Resistant, Month 9, rep1 |
| GSM7287681 |
BT474, Resistant, Month 9, rep2 |
| GSM7287682 |
BT474, Resistant, Month 9, rep3 |
|
| This SuperSeries is composed of the following SubSeries: |
| GSE231524 |
DUSP6 inhibition overcomes Neuregulin/HER3-driven therapy resistance in HER2+ breast cancer [MDA] |
| GSE231525 |
DUSP6 inhibition overcomes Neuregulin/HER3-driven therapy resistance in HER2+ breast cancer [BT474] |
|
| Relations |
| BioProject |
PRJNA966201 |
|
|
|
|
 |
Less...
More...